PODCAST

CME

ReachMD

science & medicine medicine

All Episodes

00:00:00

Bronchiectasis Update: Diagnostic Innovations and...

CME ·

2025/09/19

Host: Christopher J. Richards, MD Host: Ashley Losier, MD Bronchiectasis is complex, often underdiagnosed, and frequently misunderstood. Explore key contributors to disease progression, including the role of neutrophilic inflammation and neutrophilic serine proteases, and learn to distinguish bronchiectasis from other respiratory conditions and assess patient risk factors that impact outcomes. This module covers how pulmonary exacerbations influence disease course and highlights

00:00:00

Clinical and Safety Outcomes from the LIGHTSITE III...

CME ·

2025/09/16

Faculty: David Boyer, MD Faculty: Diana V. Do, MD This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

00:00:00

Sustaining Visual Benefits of Photobiomodulation in...

CME ·

2025/09/16

Faculty: Marion Munk, MD, Ph.D Faculty: David Boyer, MD This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

00:00:00

Real-World Evidence of Photobiomodulation Efficacy in...

CME ·

2025/09/16

00:00:00

Photobiomodulation: A Non-Invasive Treatment for...

CME ·

2025/09/16

Guest: Janis T. Eells, Ph.D. This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

00:00:00

Best Practices for Optimized Photobiomodulation...

CME ·

2025/09/16

Faculty: Marion Munk, MD, Ph.D Faculty: Diana V. Do, MD This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

00:00:00

Patient-Centered Care and Integration of...

CME ·

2025/09/16

Faculty: Diana V. Do, MD Faculty: Marion Munk, MD, Ph.D This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

00:00:00

Integration of Photobiomodulation Therapy into the...

CME ·

2025/09/16

Faculty: David Boyer, MD Faculty: Marion Munk, MD, Ph.D This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

00:00:00

Anatomical Outcomes from the LIGHTSITE III Trial

CME ·

2025/09/16

Faculty: Diana V. Do, MD Faculty: David Boyer, MD This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

00:00:00

CETP Inhibition with Obicetrapib: Implications for...

CME ·

2025/09/02

Host: Stephen Nicholls, FRACP, FACC, FESC, FAHA This program is intended for health care professionals only. Dr. Stephen Nicholls reveals new data on obicetrapib— showing promise in reducing cardiovascular events.

00:00:00

Advances in the Treatment of Neuropsychiatric...

CME ·

2025/08/28

Host: Marwan Sabbagh, MD, FAAN Guest: Alireza Atri, MD, PhD Guest: Christoph U. Correll, MD Neuropsychiatric symptoms (NPS) associated with Alzheimer’s disease (AD), such as psychosis and agitation, affect up to 50% of individuals with AD yet remain underdiagnosed and undertreated in clinical practice. These symptoms accelerate cognitive decline, increase mortality risk, and substantially worsen patient and caregiver quality of life. This broadcast replay will provide a

00:00:00

Optimizing IgAN Care: Achieving Lower Proteinuria...

CME ·

2025/08/27

Host: Jonathan Barratt, MD, PhD Faculty: Sydney Tang, MBBS, MD In this episode of Clinical Countdown, Professors Jonathan Barratt and Sydney Tang discuss the evolving treatment strategies for IgA nephropathy, focusing on lowering proteinuria through combination therapy. They examine differences in disease presentation across global populations and emphasize updated KDIGO guidance on aggressive proteinuria reduction targets. The discussion includes evidence from the PROTECT trial

00:00:00

The Evolving Landscape of Resectable Locally Advanced...

CME ·

2025/08/22

Faculty: Ravindra Uppaluri, MD, PhD This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven investigation into combining radiation and immunotherapy. Emerging clinical trial data are discussed, including the impact of

00:00:00

Rationale for Combining Radiation and Immunotherapy...

CME ·

2025/08/22

Faculty: Nancy Lee, MD, FASTRO This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven investigation into combining radiation and immunotherapy. Emerging clinical trial data are discussed, including the impact of

00:00:00

Risk Stratification and Patient Selection for...

CME ·

2025/08/22

Faculty: Douglas Adkins, MD This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven investigation into combining radiation and immunotherapy. Emerging clinical trial data are discussed, including the impact of perioperative

00:00:00

Multidisciplinary Collaboration Facilitates...

CME ·

2025/08/22

Faculty: Douglas Adkins, MD Faculty: Ravindra Uppaluri, MD, PhD Faculty: Nancy Lee, MD, FASTRO This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven investigation into combining radiation and immunotherapy

00:00:00

Applying Perioperative ICIs in Clinical Practice

CME ·

2025/08/22

Host: Douglas Adkins, MD This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven investigation into combining radiation and immunotherapy. Emerging clinical trial data are discussed, including the impact of perioperative

00:00:00

Resectable Head & Neck Cancer: A Team-Based Approach...

CME ·

2025/08/22

Host: Robert Haddad, MD Host: Ravindra Uppaluri, MD, PhD Host: Nancy Lee, MD, FASTRO Join our expert panel as they explore the evolving treatment landscape of resectable locally advanced head and neck squamous cell carcinoma. Learn how perioperative immune checkpoint inhibitors are improving event-free survival and get practical insights on applying this data to clinical care. The discussion highlights the importance of early multidisciplinary collaboration and offers

00:00:00

Emerging Evidence for Perioperative ICIs in Locally...

CME ·

2025/08/22

00:00:00

Managing Immune-Related Adverse Events in the...

CME ·

2025/08/22

343 results

CME

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事